CHCHD2 indicates a poor prognosis and is overexpressed in hepatocellular carcinoma, breast tumor, non-small cell lung carcinoma, and renal cell carcinoma (64, 65). This evidence concerns the gene CHCHD2 and hereditary clear cell renal cell carcinoma.